Severe mitral regurgitation from Libman-Sacks endocarditis treated with MitraClip: a case report

Wong Ningyan1, Ignasius Aditya Jappar1, Ewe See Hooi1

  • 1Department of Cardiology, National Heart Centre, 5 Hospital Drive, Singapore 169609, Singapore.

Insights

Transcatheter edge-to-edge repair (TEER) offers a viable treatment for severe mitral regurgitation in systemic lupus erythematosus (SLE) patients, avoiding high-risk surgery.

Area of Science:

  • Cardiology
  • Rheumatology
  • Interventional Cardiology

Background:

  • Systemic lupus erythematosus (SLE) can cause valvulopathy, typically treated with surgery.
  • SLE patients often have comorbidities, increasing surgical risks and mortality.
  • Severe mitral regurgitation (MR) in SLE necessitates treatment but poses challenges.

Observation:

  • A 41-year-old woman with SLE and antiphospholipid syndrome presented with severe MR due to Libman-Sacks endocarditis.
  • She had multiple comorbidities, including lupus nephritis and respiratory compromise, making her a high surgical risk.
  • Her heart failure progressed, with worsening symptoms and reduced left ventricular function.

Findings:

  • Transcatheter edge-to-edge repair (TEER) using the MitraClip system was successfully performed.
  • The patient improved to New York Heart Association functional Class II with mild MR at 1-month follow-up.
  • This indicates a positive outcome for a high-risk patient.

Implications:

  • TEER is a potential alternative to surgery for severe MR in SLE patients with suitable anatomy.
  • This minimally invasive approach may reduce morbidity and mortality in this vulnerable population.
  • Further research should explore TEER's long-term efficacy in SLE valvulopathy.
Abstract

Related Concept Videos

Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
Mitral Regurgitation II: Clinical Features and Diagnostic Tests01:23

Mitral Regurgitation II: Clinical Features and Diagnostic Tests

Mitral regurgitation (MR) is a valvular heart disorder in which the mitral valve fails to close tightly, allowing blood to leak backward into the heart. Understanding the clinical manifestations, assessment, diagnostic findings, and medical management of MR is crucial to effectively managing affected patients.Clinical Manifestations of Mitral RegurgitationMitral regurgitation can be acute or chronic, each presenting differently and requiring different approaches:1. Acute Mitral...
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
Mitral Regurgitation IV: Nursing Management01:28

Mitral Regurgitation IV: Nursing Management

Mitral regurgitation (MR) is a condition where the mitral valve does not close properly, leading to the backward flow of blood from the left ventricle into the left atrium during systole. This condition can arise from various causes, including rheumatic fever, infective endocarditis, or degenerative valve disease. Effective nursing management is crucial to optimizing patient outcomes and involves comprehensive assessment and targeted interventions.Comprehensive Patient AssessmentA detailed...
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...